P. Moritz Becher

Cardiologist at University Heart & Vascular Center Hamburg | Karolinska Institutet @karolinskainst | Interventional Cardiology & Heart Failure

[Jan Biegus @JanBiegus]

Digoxin in HFrEF. Welcome back????#ESCCONGRRSS #ESCcongress
@jozinetm @corneliacrm @ydaryani @mirvatalasnag @giuliamasiero3 @Angie_Durante89 @O_Azizy_MD @IzaUchmanowicz @SMosteoru @ozcan__basaran @MSBBrandao @JGrapsa @marcin_kurzyna @JSabatino86 @EWGCCEChair @Rhythmisit

[Johann Bauersachs @JBauersachsMD]

#DIGIT_HF will change clinical practice for patients with #HFrEF ‼️

⁦@ShelleyZieroth⁩ ⁦@DavidDuncker⁩ ⁦@escardio⁩ #ESCCongress2025 ⁦@YoungDgk⁩ ⁦@DGK_org⁩ ⁦@NEJM⁩

[Johann Bauersachs @JBauersachsMD]

@HFA_President @escardio @MarcoMetra @jozinetm @slumberbell @AmrAbdin10 @WilfriedMullens @corneliacrm @HanCardiomd @SotiriaLiori @_antocannata @h_arfsten @GTersalvi @hvanspall And clearly do not miss Hotline 1, Friday 11-12.00‼️
➡️ Main results of the #DIGIT_HF trial investigating #Digitoxin vs Placebo in #HFrEF🔥

@SamiraSoltaniMD @ShelleyZieroth @escardio #ESCCongress #heartfailure @slumberbell @GiuseppeGalati_ @EJHFEiC

[EHJOpen Editor-in-Chief @ehjopen]

#OpenUpYourScience with #EHJOpen!

[Andreas Metzner @AndreasMetzner7]

Another great #AFFERA training course with EP colleagues and friends from Japan @UHZ Hamburg-Eppendorf! A big THANK YOU to our great EP-team and to #Medtronic for an amazing day! @AndreasRillig @CarstenLeopold

[Evelyne Meekers @EvelyneMeekers]

📢 Results of our EASY-STOP study now presented #LBCT at #HeartFailure2025! A thread 🧵
1/ 🚀 First study to evaluate home-based #UNa using a POC sensor to guide loop diuretic downtitration in chronic #HeartFailure patients. #Cardiology #FOAMed

[Johann Bauersachs @JBauersachsMD]

#HeartFailure2025
🔥Hotline starts 10.45 with
➡️ #DIGIT_HF baseline characteristics‼️

Simultaneous publication in #EJHF 🔥

✅main results reg #Digitoxin in #HFrEF to be presented at ➡️ ⁦@escardio⁩ in Madrid

⁦@slumberbell⁩ ⁦@markcpetrie20⁩
⁦@EJHFEiC⁩

[Novi Yanti Sari @slumberbell]

DIGIT-HF baseline characteristics, was presented by #UdoBavendiek. It dives into the role of #Digoxin in today’s #HF landscape:

📍 Evaluates efficacy & safety of #Digoxin when added to well-implemented #GDMT 💊
�� Focused on patients with more pronounced HF symptoms 🫀
📍results will be presented at #ESCongress in Madrid

#HeartFailure2025 @escardio
@JBauersachsMD @ShelleyZieroth @jozinetm @corneliacrm @GTersalvi

[AFNET @afnet_ev]

Prof. Paulus Kirchhof kicked off the day at the 10th #AFNET #EHRA Consensus Conference 2025 with a short opening speech. Looking forward to engaging discussions and inspiring talks in todays sessions. #Afib @EHRAPresident @escardio #H2020MAESTRIA #heart @H2020Maestria

[Johann Bauersachs @JBauersachsMD]

🔥hot of the press:
Final Protocol of #DIGIT_HF with key amendments of Study design.
Digitoxin in #HFrEF.
Looking forward to baseline characteristics to be published at HFA Congress in Belgrade, and main results at ESC Congress in Madrid
⁦@EJHFEiC⁩ https://t.co/kcU2jyJqh6

[Michael Klinkhammer @klinki_hh]

Happy Weekend. 🫀 Heute mit der ersten Ausgabe der "Hamburg Pumps", dem Herzinsuffizienz Summit des @UKEHamburg.

@DGK_org @AGIKinterv @AGEP_DGK @HolgerNef @KardiologieHH @kaschenke @ChristophMaack @moritz_becher @Herzmedizin_de @AndreasMetzner7

[Massimiliano Camilli @Massimi78530343]

🫀🌟Be part of the first ESC endorsed Cardio-Oncology Congress with experts from all over the world🌍. 👨‍💻👩‍💻Send your highly-impact research and educative cases and discuss with the largest Cardio-Oncology community 🔬💊🧬🧪@TeresaLpezFdez1 @escardio @ESCardioNews

[European Society of Cardiology Journals @ESC_Journals]

COPD vs. Heart Failure. Take a look at #ESCHeartFailure: “Phenotyping patients with chronic obstructive pulmonary disease and heart failure.” 👉 https://t.co/foTwoFBEbq

@EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @jozinetm @MarcoMetra @GianluSava

[EJHF Editor-in-Chief @EJHFEiC]

Discontinuation and reinitiation of #MRAs in patients with heart failure and reduced ejection fraction
@ESC_Journals @GianluSava

https://t.co/9nVYE3m4QI #EJHF @HanCardiomd @AmrAbdin10 @GiuseppeGalati_

[European Society of Cardiology Journals @ESC_Journals]

The in-depth review paper on central hemodynamics in #HFpEF. Supine vs. upright test? “Invasive haemodynamic assessment in HFpEF” 👉👉👉 https://t.co/6h2CXIKCq3

@EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @AlexMebazaa @jozinetm @MarcoMetra

[Muthu Vaduganathan @mvaduganathan]

@kaulcsmc @JACCJournals @JAMACardio @NatureMedicine @gcfmd @SJGreene_md @UoGHeartFailure @brendonneuen @DmitryAbramovMD @ShelleyZieroth @yreddyhf @AndrewFoy82 @CardiacRX Given the heightened burden of hospitalizations in older adults with HF, a modest relative reduction still translates to a meaningful absolute reduction in events

Example: NNT was only 26 py to prevent 1 hospitalization of any cause in #DELIVER with #SGLT2i in HFmrEF/HpEF

[Andreas Metzner @AndreasMetzner7]

🫵Tell us your truth: your oponion on AF ablation related complications, an #EHRA SIC survey! Be part of it!🫵💪🙏

@AndreasRillig @laura_rottner @chris_sohns @ASaguner @FraSantoroMD @PerWenzel @HamburgBeats

https://t.co/vJcB6QsmMm

[ESC Heart Failure Journal @ESCHeartFailure]

🌬️💔 Did you know? #COPD is present in 1 in 8 #hf patients. Higher prevalence in #HFpEF!
COPD + HF
🔹 Higher mortality & hospitalization risk
🔹 Greater comorbidity burden
🔹 More severe HF symptoms
https://t.co/Wk2mOFHqo7

@PiotrPonikowski @CamillaHage @GMCRosano @GianluSava

[P. Moritz Becher @moritz_becher]

#StephanRosenkranz #FrancescoCosentino @GMCRosano @ESCHeartFailure @FBraunschweig @PiotrPonikowski @JanBiegus #HFA_ESC #HF #CardioTwitter @MarcoMetra @HFA_President

[P. Moritz Becher @moritz_becher]

New data on the role of COPD in HF across the EF spectrum using data from the SwedeHF online now! Special thanks to: @GianluSava #FelixLindberg #LinaBenson @CamillaHage #UlfDahlström #LarsLund #PaulusKirchhof #StefanBlankenberg
https://t.co/mOHuwhFWrg